Literature DB >> 28434838

Comment re: "Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping".

A Wannhoff1, K H Weiss1, T Hackert2, D N Gotthardt3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28434838     DOI： 10.1016/j.pan.2017.04.006

Source DB:  PubMed          Journal:  Pancreatology        ISSN： 1424-3903            Impact factor:   3.996


× No keyword cloud information.
  2 in total

1.  Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer.

Authors:  Toshiya Abe; Chiho Koi; Shiro Kohi; Ki-Byung Song; Koji Tamura; Anne Macgregor-Das; Naoki Kitaoka; Miguel Chuidian; Madeline Ford; Mohamad Dbouk; Michael Borges; Jin He; Richard Burkhart; Christopher L Wolfgang; Alison P Klein; James R Eshleman; Ralph H Hruban; Marcia Irene Canto; Michael Goggins
Journal:  Clin Gastroenterol Hepatol       Date:  2019-10-30       Impact factor: 11.382

2.  Validation of a genotype-based algorithm that identifies individuals with low, intermediate, and high serum CA19-9 levels in cancer-free individuals and in patients with colorectal cancer.

Authors:  Andreas Wannhoff; Simone Werner; Sha Tao; Hermann Brenner; Daniel N Gotthardt
Journal:  J Gastrointest Oncol       Date:  2022-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.